Published in Biomed Rep on August 24, 2012
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med (1996) 22.46
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology (2008) 6.75
Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology (2009) 4.90
Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50
Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med (1984) 2.76
Test characteristics of alpha-fetoprotein for detecting hepatocellular carcinoma in patients with hepatitis C. A systematic review and critical analysis. Ann Intern Med (2003) 2.51
Quantitation of hepatitis B virus genomic DNA by real-time detection PCR. J Clin Microbiol (1999) 2.46
Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology (1994) 2.26
Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology (2003) 2.05
Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl (2002) 2.03
Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett (1999) 1.96
Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis. Hepatology (2002) 1.72
Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50
Liver transplantation for hepatocellular carcinoma. Ann Surg (2001) 1.46
Elevations in serum alpha-fetoprotein levels in patients with chronic hepatitis B. Cancer (1989) 1.43
Early detection of hepatocellular carcinoma by real-time ultrasonography. A prospective study. Cancer (1985) 1.43
Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol (2007) 1.38
Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol (2008) 1.37
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33
Newer markers for hepatocellular carcinoma. Gastroenterology (2004) 1.31
The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol (2007) 1.30
Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size. Am J Gastroenterol (2006) 1.29
Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant (2008) 1.26
Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg (2003) 1.20
Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br J Cancer (2003) 1.10
Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma. J Gastroenterol (2007) 1.06
The situation with cancer control in Vietnam. Jpn J Clin Oncol (2002) 1.06
The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer (2003) 1.03
Clinical evaluation of lentil lectin-reactive alpha-fetoprotein-L3 in histology-proven hepatocellular carcinoma. Int J Biol Markers (2001) 0.98
Variations in the core promoter/pre-core region in HBV genotype C in Japanese and Northern Vietnamese patients. J Med Virol (2007) 0.96
Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev (2009) 0.95
Usefulness of serum des-gamma-carboxy prothrombin in detection of hepatocellular carcinoma. World J Gastroenterol (2005) 0.95
Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C. Hepatol Int (2009) 0.92
Surveillance for hepatocellular carcinoma. Semin Oncol (2001) 0.91
Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam. J Med Virol (2004) 0.90
PIVKA-II-producing advanced gastric cancer. Int J Clin Oncol (2004) 0.86
Clinical utility of prothrombin induced by vitamin K absence in the detection of hepatocellular carcinoma in Indian population. Hepatol Int (2010) 0.86
Protein induced by vitamin K absence or antagonist II-producing gastric cancer. World J Gastrointest Pathophysiol (2010) 0.85
Genotype and variations in core promoter and pre-core regions are related to progression of disease in HBV-infected patients from Northern Vietnam. Int J Mol Med (2007) 0.81
Temporal trends of cancer incidence in Vietnam, 1993-2007. Asian Pac J Cancer Prev (2010) 0.81